Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medicines Company (MDCO)

Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medicines Company 8 SYLVAN WAY PARSIPPANY NJ 07054 USA

www.themedicinescompany.com P: 973-290-6000

Description:

The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care.

Key Statistics

Overview:

Market Capitalization, $K 6,768,482
Shares Outstanding, K 79,723
Annual Sales, $ 6,140 K
Annual Net Income, $ -123,160 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -73,990 K
60-Month Beta 1.10
% of Insider Shareholders 8.41%
Float, K 73,018
% Float 91.59%

Growth:

1-Year Return 375.36%
3-Year Return 134.34%
5-Year Return 244.70%
5-Year Revenue Growth -99.11%
5-Year Earnings Growth -332.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.72 on 10/30/19
Latest Earnings Date 02/26/20
Earnings Per Share ttm -2.98
EPS Growth vs. Prev Qtr -29.58%
EPS Growth vs. Prev Year -24.32%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MDCO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -25.70%
Profit Margin % -2,005.86%
Debt/Equity -7.81
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.75
Interest Coverage -4.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar